Alexion, now part of AstraZeneca, seeks a senior analytical leader to drive late-stage strategy across CMC programs including method transfer/validation and regulatory submissions. You will lead cross-functional teams, oversee QC testing, and author CTD modules and responses to health authorities.
The role emphasizes strong technical expertise in chromatography, bioassays, and compendia compliance (USP/EP/JP) and requires proven experience managing development projects through the biologics
#J-18808-LjbffrLate-Stage Analytical Development & CMC Lead (Biologics) in new haven at Unknown Company
This position is listed as full time and onsite.